Latest news

DEBIOPHARM S.A. licenses-in a compound from Genodyssee S.A.

Debiopharm S.A. provides funding to Tulane University

Debiopharm S.A. announces a patent application on a hydrosoluble prodrug of cyclosporin A

Debiopharm S.A. licenses-in new technology to turn injectable macromolecular drugs into oral formulations

Debiopharm and Biolex sign collaboration

Debiopharm extends its collaboration with Sanofi-Synthélabo on Eloxatin®

Media Alert: successful registration after shortest ever review by the FDA of Eloxatin

Dyax Corp. and Debiopharm S.A. report successful results of phase IIA clinical trial with DX-890 for cystic fibrosis

Debiopharm S.A. inaugurates a new State-of-the-Art Galenic Unit in Gland, Switzerland